Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1300 of 2529 entries
View as:

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03301896 Org: User:
Start: 01/31/18 End: 06/30/22 Due: 06/30/23

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Phase: N/A Priority: Normal
NCT ID: NCT00790816 Org: User:
Start: 10/31/08 End: 08/19/16 Due: 08/19/17

Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01353508 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00622258 Org: User:
Start: 03/31/08 End: 01/31/14 Due: 01/31/15

Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04993157 Org: User:
Start: 12/10/21 End: 06/28/22 Due: 06/28/23

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Phase: N/A Priority: Normal
NCT ID: NCT01227577 Org: User:
Start: 11/30/10 End: 11/30/14 Due: 11/30/15

Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05135000 Org: User:
Start: 06/30/22 End: 04/25/24 Due: 04/25/25

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01029652 Org: User:
Start: 12/31/09 End: 10/31/10 Due: 10/31/11

Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT01934361 Org: User:
Start: 02/28/14 End: 07/07/16 Due: 07/07/17

Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT01737827 Org: User:
Start: 03/25/13 End: 05/24/23 Due: 05/24/24

Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry

Phase: N/A Priority: Normal
NCT ID: NCT06903234 Org: User:
Start: 03/31/25 End: 10/01/29 Due: 10/01/30

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01254188 Org: User:
Start: 04/30/11 End: 11/30/14 Due: 11/30/15

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01428297 Org: User:
Start: 05/31/11 End: 02/28/14 Due: 02/28/15

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT04104776 Org: User:
Start: 09/18/19 End: 02/27/30 Due: 02/27/31

Real-World Use of Novel Treatments in Patients With Spinal Muscular Atrophy (SMA): A Multi-Site Retrospective Chart Review of Pediatric SMA Patients Outside of the United States

Phase: N/A Priority: Normal
NCT ID: NCT06178393 Org: User:
Start: 05/05/22 End: 12/30/22 Due: 12/30/23

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

Phase: N/A Priority: Normal
NCT ID: NCT04593927 Org: User:
Start: 10/28/20 End: 08/30/23 Due: 08/30/24

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01599104 Org: User:
Start: 06/30/12 End: 04/30/13 Due: 04/30/14

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Phase: N/A Priority: Normal
NCT ID: NCT00046254 Org: User:
Start: 02/28/02 End: 02/28/07 Due: 02/28/08

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04939610 Org: User:
Start: 07/30/21 End: 06/30/28 Due: 06/30/29

Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT00654589 Org: User:
Start: 02/29/08 End: 01/31/12 Due: 01/31/13

Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

Phase: N/A Priority: Normal
NCT ID: NCT00233337 Org: User:
Start: 05/31/01 End: 08/31/05 Due: 08/31/06

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT01589237 Org: User:
Start: 02/28/13 End: 07/31/15 Due: 07/31/16

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05344482 Org: User:
Start: 07/09/20 End: 08/31/21 Due: 08/31/22

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Phase: N/A Priority: Normal
NCT ID: NCT01636687 Org: User:
Start: 10/17/12 End: 10/27/16 Due: 10/27/17

Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00600886 Org: User:
Start: 02/11/08 End: 03/11/16 Due: 03/11/17